BridgeBio Pharma, Inc.
Industry: Life Sciences ・ $BBIO on Nasdaq
Insider Sale
+$149,350,000
-18.67%
Shares
Shares Volume: 5,800,000 Shares
Average Share Price: $25.75
INSIDER
KKR Genetic Disorder L.P.
10% Owner
reported on Sep 17 2024
traded on Sep 13 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 25,260,971 |
| PURCHASES/SALES 1Y | 0 / 1 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $149,350,000 |
| INSIDER PREVIOUS TRADES | No trades in past 1Y |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 12 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $13,086,647.08 |
| COMPANY PREVIOUS TRADES |